Skip to main content
Amrita Krishnan, MD, Oncology, Irvine, CA, City of Hope Comprehensive Cancer Center

AmritaKrishnanMD

Oncology Irvine, CA

Hematologic Oncology

Director Multiple Myeloma Program: Professor of Medicine

Dr. Krishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Krishnan's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1990 - 1993
  • Albany Medical College
    Albany Medical CollegeClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - 2025
  • NY State Medical License
    NY State Medical License 1991 - 1994
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Proteasome Inhibitors Impair the Innate Antiviral Immune Response and Potentiate Pelareorep-Based Viral Therapy in Multiple Myeloma
    Amrita Y. Krishnan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Lo...
    Amrita Y. Krishnan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Current Obstacles in Myeloma Management: Debating the Evidence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Split First Dose Administration of Daratumumab for the Treatment of Patients with Multiple Myeloma (MM): Clinical Pharmacology and Population Pharmacokinetic (PK) Anal... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • City of Hope O.C. Offers Sneak Peek at Coming Irvine Cancer Hospital
    City of Hope O.C. Offers Sneak Peek at Coming Irvine Cancer HospitalMarch 28th, 2023
  • Multiple Myeloma Squad (Don’t Call It ‘Cancer Club’) Is on a Mission for Life
    Multiple Myeloma Squad (Don’t Call It ‘Cancer Club’) Is on a Mission for LifeAugust 31st, 2021
  • City of Hope Physicians and Scientists Present New Immunotherapy Research at ASCO Virtual Conference
    City of Hope Physicians and Scientists Present New Immunotherapy Research at ASCO Virtual ConferenceJune 3rd, 2021
  • Join now to see all

Hospital Affiliations